Older adults taking memantine for Alzheimer’s disease may face a higher risk of irregular heartbeats, according to a growing body of evidence drawn from electronic health records and adverse-event ...
WALTON COUNTY, Fla. (WJHG/WECP) - Walton County firefighters, paramedics, and EMTs are receiving hands-on EKG training from Ascension Sacred Heart physicians. First responders are learning in-depth ...
Please provide your email address to receive an email when new articles are posted on . A novel leadless conduction system pacemaker conferred stable pacing parameters at 1 month. The device dislodged ...
Please provide your email address to receive an email when new articles are posted on . A bipolar conduction system pacing implantable cardioverter defibrillator lead met safety and effectiveness ...
Some of the technologies that made headlines at HRS 2026. [Images courtesy of J&J, iRhythm, Abbott and Medtronic] Over the last weekend, Chicago played host to the 2026 edition of the Heart Rhythm ...
At the April 2026 Heart Rhythm Society Annual Meeting in Chicago, panelists gathered to discuss a myriad of topics in the rapidly growing cardiovascular care space. Song Zuo, MD, a specialist at the ...
Alivecor Inc. has secured CE marking for its Kardia 12L electrocardiogram (ECG) system, which is powered by its KAI 12L AI technology and can detect life-threatening cardiac conditions. Kardia 12L is ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI™ algorithm for cardiac amyloidosis (CA) ...
Medtronic got an FDA approval for its OmniaSecure defibrillation lead, opening up its use in the heart’s left bundle branch, while Biotronik touted the commercial rollout of its Solia CSP S lead.
Discordant results from two trials comparing conduction system pacing with biventricular pacing for cardiac resynchronization therapy (CRT) leave open the question of whether conduction system pacing ...
Conduction-system pacing (CSP) was put to the test in two randomized trials of patients requiring cardiac resynchronization therapy (CRT) for left bundle branch block (LBBB)—the HeartSync-LBBP and ...